Inagaki Y - Search Results

1

Chinese medicine as complementary therapy for female infertility.

Xia JF, Inagaki Y, Zhang JF, Wang L, Song PP. Xia JF, et al. Among authors: inagaki y. Chin J Integr Med. 2017 Apr;23(4):245-252. doi: 10.1007/s11655-016-2510-5. Epub 2016 Aug 2. Chin J Integr Med. 2017. PMID: 27484764 Review.

2

Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus.

Xia J, Inagaki Y, Song P, Sawakami T, Kokudo N, Hasegawa K, Sakamoto Y, Tang W. Xia J, et al. Among authors: inagaki y. Biosci Trends. 2016 Nov 15;10(5):327-336. doi: 10.5582/bst.2016.01110. Epub 2016 Jun 25. Biosci Trends. 2016. PMID: 27350107 Free article. Review.

3

Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways.

Xia J, Inagaki Y, Gao J, Qi F, Song P, Han G, Sawakami T, Gao B, Luo C, Kokudo N, Hasegawa K, Sakamoto Y, Tang W. Xia J, et al. Among authors: inagaki y. Am J Chin Med. 2017;45(7):1537-1556. doi: 10.1142/S0192415X17500835. Epub 2017 Sep 25. Am J Chin Med. 2017. PMID: 28946772

4

Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line.

Xia JF, Gao JJ, Inagaki Y, Kokudo N, Nakata M, Tang W. Xia JF, et al. Among authors: inagaki y. Drug Discov Ther. 2013 Feb;7(1):1-8. doi: 10.5582/ddt.2013.v7.1.1. Drug Discov Ther. 2013. PMID: 23524937 Free article. Review.

5

Intractable and rare diseases research in Asia.

Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Song P, et al. Among authors: inagaki y. Biosci Trends. 2012 Apr;6(2):48-51. Biosci Trends. 2012. PMID: 22621985 Free article.

6

Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Song P, Gao J, Inagaki Y, Kokudo N, Tang W. Song P, et al. Among authors: inagaki y. Intractable Rare Dis Res. 2012 Feb;1(1):3-9. doi: 10.5582/irdr.2012.v1.1.3. Intractable Rare Dis Res. 2012. PMID: 25343064 Free PMC article. Review.

7

Necessity of cooperation with government on publication of scientific research results for intractable diseases.

Inagaki Y, Song P. Inagaki Y, et al. Intractable Rare Dis Res. 2013 May;2(2):69-71. doi: 10.5582/irdr.2013.v2.2.69. Intractable Rare Dis Res. 2013. PMID: 25343106 Free PMC article.

8

Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.

Xia J, Rong L, Sawakami T, Inagaki Y, Song P, Hasegawa K, Sakamoto Y, Tang W. Xia J, et al. Among authors: inagaki y. Biomed Pharmacother. 2018 Mar;99:921-930. doi: 10.1016/j.biopha.2018.01.163. Epub 2018 Feb 20. Biomed Pharmacother. 2018. PMID: 29710492

9

Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies.

Song P, Inagaki Y, Sugawara Y, Kokudo N. Song P, et al. Among authors: inagaki y. Biosci Trends. 2013 Jun;7(3):157-8. Biosci Trends. 2013. PMID: 23836040 Free article.

10

Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W. Song P, et al. Among authors: inagaki y. Liver Cancer. 2013 Jan;2(1):31-9. doi: 10.1159/000346220. Liver Cancer. 2013. PMID: 24159594 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,174 results

Search Page